James Mackaness - CHIEF FINANCIAL OFFICER at Soleno Therapeutics Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
SLNO on Nasdaq
All Insider Reports
All Insider Reports

James Mackaness - trading volume in the past year for Soleno Therapeutics Inc

Holdings reported by James Mackaness for Soleno Therapeutics Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 119K $5.99M $50.25 Oct 1, 2024 Direct
Employee stock option (right to buy) 37K Jan 4, 2024 Direct Common Stock
Warrants (right to buy) 0 $0.44 Oct 2, 2023 Direct Common Stock

Transactions reported by James Mackaness for Soleno Therapeutics Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.